Software - Infrastructure
Compare Stocks
4 / 10Stock Comparison
EXOD vs SMLR vs MSTR vs CLSK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Software - Application
Software - Application
EXOD vs SMLR vs MSTR vs CLSK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Infrastructure | Medical - Devices | Software - Application | Software - Application |
| Market Cap | $145M | $311M | $60.05B | $3.58B |
| Revenue (TTM) | $122M | $37M | $490M | $785M |
| Net Income (TTM) | $0.00 | $48M | $-12.36B | $-261M |
| Gross Margin | 60.5% | 90.8% | 68.1% | 41.4% |
| Operating Margin | -6.3% | -94.7% | 94.2% | -26.4% |
| Forward P/E | 1516.0x | 4.0x | 2.4x | 12.5x |
| Total Debt | $0.00 | $70K | $8.28B | $824M |
| Cash & Equiv. | $5M | $9M | $2.30B | $43M |
EXOD vs SMLR vs MSTR vs CLSK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Exodus Movement, In… (EXOD) | 100 | 36.1 | -63.9% |
| Semler Scientific, … (SMLR) | 100 | 12.2 | -87.8% |
| Strategy Inc (MSTR) | 100 | 310.9 | +210.9% |
| CleanSpark, Inc. (CLSK) | 100 | 120.6 | +20.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXOD vs SMLR vs MSTR vs CLSK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXOD lags the leaders in this set but could rank higher in a more targeted comparison.
SMLR carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 2.48, Low D/E 0.0%, current ratio 3.59x
- 130.8% margin vs MSTR's -25.2%
- Beta 2.48 vs CLSK's 3.39, lower leverage
- 8.1% ROA vs MSTR's -19.4%, ROIC 13.3% vs -9.9%
MSTR is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 1 yrs, beta 2.59, yield 0.7%
- 8.6% 10Y total return vs SMLR's 11.1%
- Beta 2.59, yield 0.7%, current ratio 5.62x
- Lower P/E (2.4x vs 12.5x)
CLSK is the clearest fit if your priority is growth exposure.
- Rev growth 102.2%, EPS growth 262.3%, 3Y rev CAGR 79.9%
- 102.2% revenue growth vs SMLR's -17.4%
- +74.1% vs EXOD's -81.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 102.2% revenue growth vs SMLR's -17.4% | |
| Value | Lower P/E (2.4x vs 12.5x) | |
| Quality / Margins | 130.8% margin vs MSTR's -25.2% | |
| Stability / Safety | Beta 2.48 vs CLSK's 3.39, lower leverage | |
| Dividends | 0.7% yield, 1-year raise streak, vs CLSK's 0.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +74.1% vs EXOD's -81.1% | |
| Efficiency (ROA) | 8.1% ROA vs MSTR's -19.4%, ROIC 13.3% vs -9.9% |
EXOD vs SMLR vs MSTR vs CLSK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
EXOD vs SMLR vs MSTR vs CLSK — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EXOD leads in 1 of 6 categories
SMLR leads 1 • MSTR leads 1 • CLSK leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SMLR and MSTR each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLSK is the larger business by revenue, generating $785M annually — 21.2x SMLR's $37M. SMLR is the more profitable business, keeping 130.8% of every revenue dollar as net income compared to MSTR's -25.2%. On growth, MSTR holds the edge at +11.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $122M | $37M | $490M | $785M |
| EBITDAEarnings before interest/tax | -$8M | -$35M | $480M | $181M |
| Net IncomeAfter-tax profit | $0 | $48M | -$12.4B | -$261M |
| Free Cash FlowCash after capex | -$26M | -$389M | $7.6B | -$1.0B |
| Gross MarginGross profit ÷ Revenue | +60.5% | +90.8% | +68.1% | +41.4% |
| Operating MarginEBIT ÷ Revenue | -6.3% | -94.7% | +94.2% | -26.4% |
| Net MarginNet income ÷ Revenue | -9.3% | +130.8% | -25.2% | -33.2% |
| FCF MarginFCF ÷ Revenue | -21.0% | -10.5% | +15.5% | -133.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -36.2% | -44.6% | +11.9% | +11.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -170.3% | +48.6% | -132.0% | -2.6% |
Valuation Metrics
EXOD leads this category, winning 2 of 5 comparable metrics.
Valuation Metrics
At 4.0x trailing earnings, SMLR trades at a 68% valuation discount to CLSK's 12.5x P/E. On an enterprise value basis, CLSK's 6.5x EV/EBITDA is more attractive than SMLR's 14.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $145M | $311M | $60.1B | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $140M | $302M | $66.0B | $4.4B |
| Trailing P/EPrice ÷ TTM EPS | -19.44x | 3.96x | -11.81x | 12.48x |
| Forward P/EPrice ÷ next-FY EPS est. | 1516.00x | — | 2.37x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 0.18x | — | — |
| EV / EBITDAEnterprise value multiple | — | 14.04x | — | 6.53x |
| Price / SalesMarket cap ÷ Revenue | 1.20x | 5.52x | 125.83x | 4.67x |
| Price / BookPrice ÷ Book value/share | 0.89x | 0.70x | 1.04x | 2.04x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — |
Profitability & Efficiency
SMLR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SMLR delivers a 10.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-24 for MSTR. SMLR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLSK's 0.38x. On the Piotroski fundamental quality scale (0–9), CLSK scores 5/9 vs MSTR's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.5% | +10.5% | -24.1% | -13.7% |
| ROA (TTM)Return on assets | -4.0% | +8.1% | -19.4% | -8.5% |
| ROICReturn on invested capital | -2.5% | +13.3% | -9.9% | +10.3% |
| ROCEReturn on capital employed | -2.8% | +13.7% | -12.6% | +13.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 3 | 5 |
| Debt / EquityFinancial leverage | — | 0.00x | 0.16x | 0.38x |
| Net DebtTotal debt minus cash | -$5M | -$9M | $6.0B | $781M |
| Cash & Equiv.Liquid assets | $5M | $9M | $2.3B | $43M |
| Total DebtShort + long-term debt | $0 | $70,000 | $8.3B | $824M |
| Interest CoverageEBIT ÷ Interest expense | -13.44x | -12.85x | 9.05x | -18.49x |
Total Returns (Dividends Reinvested)
MSTR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSTR five years ago would be worth $28,983 today (with dividends reinvested), compared to $1,815 for SMLR. Over the past 12 months, CLSK leads with a +74.1% total return vs EXOD's -81.1%. The 3-year compound annual growth rate (CAGR) favors MSTR at 82.7% vs SMLR's -6.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -50.1% | +14.3% | +14.4% | +21.0% |
| 1-Year ReturnPast 12 months | -81.1% | -38.5% | -54.2% | +74.1% |
| 3-Year ReturnCumulative with dividends | +275.2% | -18.9% | +510.2% | +229.7% |
| 5-Year ReturnCumulative with dividends | -71.4% | -81.8% | +189.8% | -26.9% |
| 10-Year ReturnCumulative with dividends | -71.4% | +1110.1% | +855.6% | -84.3% |
| CAGR (3Y)Annualised 3-year return | +55.4% | -6.8% | +82.7% | +48.8% |
Risk & Volatility
Evenly matched — SMLR and CLSK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SMLR is the less volatile stock with a 2.48 beta — it tends to amplify market swings less than CLSK's 3.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CLSK currently trades 59.2% from its 52-week high vs EXOD's 13.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.23x | 2.48x | 2.59x | 3.39x |
| 52-Week HighHighest price in past year | $56.00 | $50.44 | $457.22 | $23.61 |
| 52-Week LowLowest price in past year | $5.89 | $14.88 | $104.17 | $7.91 |
| % of 52W HighCurrent price vs 52-week peak | +13.5% | +40.3% | +39.3% | +59.2% |
| RSI (14)Momentum oscillator 0–100 | 53.2 | 52.4 | 68.8 | 71.5 |
| Avg Volume (50D)Average daily shares traded | 73K | 0 | 18.8M | 19.0M |
Analyst Outlook
Evenly matched — MSTR and CLSK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EXOD as "Buy", SMLR as "Buy", MSTR as "Buy", CLSK as "Buy". Consensus price targets imply 190.2% upside for EXOD (target: $22) vs 44.6% for CLSK (target: $20). For income investors, MSTR offers the higher dividend yield at 0.72% vs CLSK's 0.24%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $22.00 | $50.50 | $280.83 | $20.21 |
| # AnalystsCovering analysts | 3 | 7 | 29 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.7% | +0.2% |
| Dividend StreakConsecutive years of raises | — | — | 1 | 2 |
| Dividend / ShareAnnual DPS | — | — | $1.30 | $0.03 |
| Buyback YieldShare repurchases ÷ mkt cap | +10.4% | 0.0% | 0.0% | +4.1% |
EXOD leads in 1 of 6 categories (Valuation Metrics). SMLR leads in 1 (Profitability & Efficiency). 3 tied.
EXOD vs SMLR vs MSTR vs CLSK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EXOD or SMLR or MSTR or CLSK a better buy right now?
For growth investors, CleanSpark, Inc.
(CLSK) is the stronger pick with 102. 2% revenue growth year-over-year, versus -17. 4% for Semler Scientific, Inc. (SMLR). Semler Scientific, Inc. (SMLR) offers the better valuation at 4. 0x trailing P/E, making it the more compelling value choice. Analysts rate Exodus Movement, Inc. (EXOD) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXOD or SMLR or MSTR or CLSK?
On trailing P/E, Semler Scientific, Inc.
(SMLR) is the cheapest at 4. 0x versus CleanSpark, Inc. at 12. 5x. On forward P/E, Strategy Inc is actually cheaper at 2. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EXOD or SMLR or MSTR or CLSK?
Over the past 5 years, Strategy Inc (MSTR) delivered a total return of +189.
8%, compared to -81. 8% for Semler Scientific, Inc. (SMLR). Over 10 years, the gap is even starker: SMLR returned +1110% versus CLSK's -84. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXOD or SMLR or MSTR or CLSK?
By beta (market sensitivity over 5 years), Semler Scientific, Inc.
(SMLR) is the lower-risk stock at 2. 48β versus CleanSpark, Inc. 's 3. 39β — meaning CLSK is approximately 37% more volatile than SMLR relative to the S&P 500. On balance sheet safety, Semler Scientific, Inc. (SMLR) carries a lower debt/equity ratio of 0% versus 38% for CleanSpark, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EXOD or SMLR or MSTR or CLSK?
By revenue growth (latest reported year), CleanSpark, Inc.
(CLSK) is pulling ahead at 102. 2% versus -17. 4% for Semler Scientific, Inc. (SMLR). On earnings-per-share growth, the picture is similar: CleanSpark, Inc. grew EPS 262. 3% year-over-year, compared to -151. 3% for Strategy Inc. Over a 3-year CAGR, CLSK leads at 79. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXOD or SMLR or MSTR or CLSK?
Semler Scientific, Inc.
(SMLR) is the more profitable company, earning 72. 7% net margin versus -844. 8% for Strategy Inc — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLSK leads at 41. 6% versus -1140. 8% for MSTR. At the gross margin level — before operating expenses — SMLR leads at 91. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXOD or SMLR or MSTR or CLSK more undervalued right now?
On forward earnings alone, Strategy Inc (MSTR) trades at 2.
4x forward P/E versus 1516. 0x for Exodus Movement, Inc. — 1513. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EXOD: 190. 2% to $22. 00.
08Which pays a better dividend — EXOD or SMLR or MSTR or CLSK?
In this comparison, MSTR (0.
7% yield), CLSK (0. 2% yield) pay a dividend. EXOD, SMLR do not pay a meaningful dividend and should not be held primarily for income.
09Is EXOD or SMLR or MSTR or CLSK better for a retirement portfolio?
For long-horizon retirement investors, Strategy Inc (MSTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0.
7% yield, +855. 6% 10Y return). CleanSpark, Inc. (CLSK) carries a higher beta of 3. 39 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSTR: +855. 6%, CLSK: -84. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXOD and SMLR and MSTR and CLSK?
These companies operate in different sectors (EXOD (Technology) and SMLR (Healthcare) and MSTR (Technology) and CLSK (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EXOD is a small-cap quality compounder stock; SMLR is a small-cap deep-value stock; MSTR is a mid-cap quality compounder stock; CLSK is a small-cap high-growth stock. MSTR pays a dividend while EXOD, SMLR, CLSK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.